List of Tables
Table 1. Global HER2 Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Key Players of Others
Table 5. Global HER2 Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global HER2 Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global HER2 Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global HER2 Targeted Therapy Market Share by Region (2020-2025)
Table 9. Global HER2 Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global HER2 Targeted Therapy Market Share by Region (2026-2031)
Table 11. HER2 Targeted Therapy Market Trends
Table 12. HER2 Targeted Therapy Market Drivers
Table 13. HER2 Targeted Therapy Market Challenges
Table 14. HER2 Targeted Therapy Market Restraints
Table 15. Global HER2 Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global HER2 Targeted Therapy Market Share by Players (2020-2025)
Table 17. Global Top HER2 Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Targeted Therapy as of 2024)
Table 18. Ranking of Global Top HER2 Targeted Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by HER2 Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of HER2 Targeted Therapy, Headquarters and Area Served
Table 21. Global Key Players of HER2 Targeted Therapy, Product and Application
Table 22. Global Key Players of HER2 Targeted Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HER2 Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global HER2 Targeted Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global HER2 Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global HER2 Targeted Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global HER2 Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global HER2 Targeted Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global HER2 Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global HER2 Targeted Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America HER2 Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America HER2 Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe HER2 Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe HER2 Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific HER2 Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific HER2 Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific HER2 Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America HER2 Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America HER2 Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa HER2 Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa HER2 Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. GlaxoSmithKline Company Details
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline HER2 Targeted Therapy Product
Table 50. GlaxoSmithKline Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Bayer Company Details
Table 53. Bayer Business Overview
Table 54. Bayer HER2 Targeted Therapy Product
Table 55. Bayer Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. Abbott Company Details
Table 58. Abbott Business Overview
Table 59. Abbott HER2 Targeted Therapy Product
Table 60. Abbott Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie HER2 Targeted Therapy Product
Table 65. AbbVie Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer HER2 Targeted Therapy Product
Table 70. Pfizer Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi HER2 Targeted Therapy Product
Table 75. Sanofi Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Agilent Company Details
Table 78. Agilent Business Overview
Table 79. Agilent HER2 Targeted Therapy Product
Table 80. Agilent Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. Glenmark Pharmaceuticals Company Details
Table 83. Glenmark Pharmaceuticals Business Overview
Table 84. Glenmark Pharmaceuticals HER2 Targeted Therapy Product
Table 85. Glenmark Pharmaceuticals Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 86. Glenmark Pharmaceuticals Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck HER2 Targeted Therapy Product
Table 90. Merck Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche HER2 Targeted Therapy Product
Table 95. Roche Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 96. Roche Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis HER2 Targeted Therapy Product
Table 100. Novartis Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Astra Zeneca Company Details
Table 103. Astra Zeneca Business Overview
Table 104. Astra Zeneca HER2 Targeted Therapy Product
Table 105. Astra Zeneca Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 106. Astra Zeneca Recent Development
Table 107. Daiichi Sankyo Company Details
Table 108. Daiichi Sankyo Business Overview
Table 109. Daiichi Sankyo HER2 Targeted Therapy Product
Table 110. Daiichi Sankyo Revenue in HER2 Targeted Therapy Business (2020-2025) & (US$ Million)
Table 111. Daiichi Sankyo Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. HER2 Targeted Therapy Picture
Figure 2. Global HER2 Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HER2 Targeted Therapy Market Share by Type: 2024 VS 2031
Figure 4. Monotherapy Features
Figure 5. Combination Therapy Features
Figure 6. Others Features
Figure 7. Global HER2 Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global HER2 Targeted Therapy Market Share by Application: 2024 VS 2031
Figure 9. Breast Cancer Case Studies
Figure 10. Stomach Cancer Case Studies
Figure 11. Head and Neck Cancer Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Ovarian Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. HER2 Targeted Therapy Report Years Considered
Figure 16. Global HER2 Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global HER2 Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global HER2 Targeted Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global HER2 Targeted Therapy Market Share by Players in 2024
Figure 20. Global Top HER2 Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Targeted Therapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by HER2 Targeted Therapy Revenue in 2024
Figure 22. North America HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America HER2 Targeted Therapy Market Share by Country (2020-2031)
Figure 24. United States HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe HER2 Targeted Therapy Market Share by Country (2020-2031)
Figure 28. Germany HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific HER2 Targeted Therapy Market Share by Region (2020-2031)
Figure 36. China HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America HER2 Targeted Therapy Market Share by Country (2020-2031)
Figure 44. Mexico HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa HER2 Targeted Therapy Market Share by Country (2020-2031)
Figure 48. Turkey HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE HER2 Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. GlaxoSmithKline Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 52. Bayer Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 53. Abbott Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 54. AbbVie Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 57. Agilent Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 58. Glenmark Pharmaceuticals Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 59. Merck Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 60. Roche Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 61. Novartis Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 62. Astra Zeneca Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 63. Daiichi Sankyo Revenue Growth Rate in HER2 Targeted Therapy Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
